{"count": 6, "results": [{"_id": "40542925", "pmid": 40542925, "title": "The metformin administration on pancreatic tissue damage in metastatic rat prostate cancer and STZ induced diabetes model.", "journal": "J Mol Histol", "authors": ["Koroglu P", "Ertik O", "Bulan OK", "Yanardag R"], "date": "2025-06-21T00:00:00Z", "doi": "10.1007/s10735-025-10478-4", "meta_date_publication": "2025 Jun 21", "meta_volume": "56", "meta_issue": "4", "meta_pages": "201", "score": 50260.855, "text_hl": "The @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration on @<m>DISEASE_Pancreatic_Diseases</m> @DISEASE_MESH:D010182 @@@pancreatic tissue damage@@@ in metastatic @SPECIES_10116 @@@rat@@@ @DISEASE_Prostatic_Neoplasms @DISEASE_MESH:D011471 @@@prostate cancer@@@ and @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@STZ@@@ induced @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ model.", "citations": {"NLM": "Koroglu P, Ertik O, Bulan OK, Yanardag R. The metformin administration on pancreatic tissue damage in metastatic rat prostate cancer and STZ induced diabetes model. J Mol Histol. 2025 Jun 21;56(4):201. PMID: 40542925", "BibTeX": "@article{40542925, title={The metformin administration on pancreatic tissue damage in metastatic rat prostate cancer and STZ induced diabetes model.}, author={Koroglu P and Ertik O and Bulan OK and Yanardag R}, journal={J Mol Histol}, volume={56}, number={4}, pages={201}}"}}, {"_id": "36058289", "pmid": 36058289, "title": "Metformin alleviates long-term high-fructose diet-induced skeletal muscle insulin resistance in rats by regulating purine nucleotide cycle.", "journal": "Eur J Pharmacol", "authors": ["Cheng J", "Xu L", "Yu Q", "Lin G", "Ma X", "Li M", "Guan F", "Liu Y", "Huang X", "Xie J", "Chen J", "Su Z", "Li Y"], "date": "2022-10-15T00:00:00Z", "doi": "10.1016/j.ejphar.2022.175234", "meta_date_publication": "2022 Oct 15", "meta_volume": "933", "meta_issue": "", "meta_pages": "175234", "score": 50246.36, "text_hl": "Results indicated that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ significantly ameliorated features of @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@, including body weight, Lee's index, @DISEASE_Hyperinsulinism @DISEASE_MESH:D006946 @@@hyperinsulinemia@@@, @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@, @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin intolerance@@@ and @<m>DISEASE_Pancreatic_Diseases</m> @DISEASE_MESH:D010182 @@@pancreatic damage@@@. ", "citations": {"NLM": "Cheng J, Xu L, Yu Q, Lin G, Ma X, Li M, Guan F, Liu Y, Huang X, Xie J, Chen J, Su Z, Li Y. Metformin alleviates long-term high-fructose diet-induced skeletal muscle insulin resistance in rats by regulating purine nucleotide cycle. Eur J Pharmacol. 2022 Oct 15;933():175234. PMID: 36058289", "BibTeX": "@article{36058289, title={Metformin alleviates long-term high-fructose diet-induced skeletal muscle insulin resistance in rats by regulating purine nucleotide cycle.}, author={Cheng J and Xu L and Yu Q and Lin G and Ma X and Li M and Guan F and Liu Y and Huang X and Xie J and Chen J and Su Z and Li Y}, journal={Eur J Pharmacol}, volume={933}, pages={175234}}"}}, {"_id": "35444531", "pmid": 35444531, "pmcid": "PMC9015648", "title": "An Overview of the Evidence and Mechanism of Drug-Herb Interactions Between Propolis and Pharmaceutical Drugs", "journal": "Front Pharmacol", "authors": ["Hossain S", "Yousaf M", "Liu Y", "Chang D", "Zhou X"], "date": "2022-04-04T00:00:00Z", "doi": "10.3389/fphar.2022.876183", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "876183", "score": 50228.96, "text_hl": "The strong antioxidant activity of @CHEMICAL_Propolis @CHEMICAL_MESH:D011429 @@@propolis@@@ also strengthened the therapeutic effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in attenuating @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and @<m>DISEASE_Pancreatic_Diseases</m> @DISEASE_MESH:D010182 @@@pancreatic damage@@@, as well as mitigating oxidative stress in the liver, kidney, and testis. ", "citations": {"NLM": "Hossain S, Yousaf M, Liu Y, Chang D, Zhou X. An Overview of the Evidence and Mechanism of Drug-Herb Interactions Between Propolis and Pharmaceutical Drugs Front Pharmacol. 2022;13():876183. PMID: 35444531", "BibTeX": "@article{35444531, title={An Overview of the Evidence and Mechanism of Drug-Herb Interactions Between Propolis and Pharmaceutical Drugs}, author={Hossain S and Yousaf M and Liu Y and Chang D and Zhou X}, journal={Front Pharmacol}, volume={13}, pages={876183}}"}}, {"_id": "30306620", "pmid": 30306620, "title": "Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes.", "journal": "Diabet Med", "authors": ["Montvida O", "Green JB", "Atherton J", "Paul SK"], "date": "2019-04-01T00:00:00Z", "doi": "10.1111/dme.13835", "meta_date_publication": "2019 Apr", "meta_volume": "36", "meta_issue": "4", "meta_pages": "491-498", "score": 50054.336, "text_hl": "Treatment with incretins does not increase the risk of @<m>DISEASE_Pancreatic_Diseases</m> @DISEASE_MESH:D010182 @@@pancreatic diseases@@@ compared to older anti-hyperglycaemic drugs, when added to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@: real world evidence in people with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 diabetes@@@.", "citations": {"NLM": "Montvida O, Green JB, Atherton J, Paul SK. Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes. Diabet Med. 2019 Apr;36(4):491-498. PMID: 30306620", "BibTeX": "@article{30306620, title={Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti-hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes.}, author={Montvida O and Green JB and Atherton J and Paul SK}, journal={Diabet Med}, volume={36}, number={4}, pages={491-498}}"}}, {"_id": "29416195", "pmid": 29416195, "pmcid": "PMC5764610", "title": "Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model", "journal": "Med Arch", "authors": ["Murai Y", "Ohta T", "Tadaki H", "Miyajima K", "Shinohara M", "Fatchiyah F", "Yamada T"], "date": "2017-12-01T00:00:00Z", "doi": "10.5455/medarh.2017.71.380-384", "meta_date_publication": "2017 Dec", "meta_volume": "71", "meta_issue": "6", "meta_pages": "380-384", "score": 50050.883, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment led to maintained good glycemic control and improved @DISEASE_Nervous_System_Diseases @DISEASE_MESH:D009422 @@@neuropathy@@@ and @<m>DISEASE_Pancreatic_Diseases</m> @DISEASE_MESH:D010182 @@@pancreatic lesions@@@ in female SDT fatty @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Murai Y, Ohta T, Tadaki H, Miyajima K, Shinohara M, Fatchiyah F, Yamada T. Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model Med Arch. 2017 Dec;71(6):380-384. PMID: 29416195", "BibTeX": "@article{29416195, title={Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model}, author={Murai Y and Ohta T and Tadaki H and Miyajima K and Shinohara M and Fatchiyah F and Yamada T}, journal={Med Arch}, volume={71}, number={6}, pages={380-384}}"}}, {"_id": "30341867", "pmid": 30341867, "title": "The Influence of Metformin on Serum Carbohydrate Antigen 19-9 (CA 19-9) Levels in Type 2 Diabetes Mellitus Patients.", "journal": "J Assoc Physicians India", "authors": ["Ankit BS", "Agrawal R", "Gadhwal A", "Chahar C", "Agrawal RP"], "date": "2018-03-01T00:00:00Z", "meta_date_publication": "2018 Mar", "meta_volume": "66", "meta_issue": "3", "meta_pages": "38-41", "score": 50042.887, "text_hl": "Results: Mean CA 19-9 level was 18.99+-4.30 U/ml in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group as compared to 30.49+-5.61 U/ml in non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group (p<0.001). ", "citations": {"NLM": "Ankit BS, Agrawal R, Gadhwal A, Chahar C, Agrawal RP. The Influence of Metformin on Serum Carbohydrate Antigen 19-9 (CA 19-9) Levels in Type 2 Diabetes Mellitus Patients. J Assoc Physicians India. 2018 Mar;66(3):38-41. PMID: 30341867", "BibTeX": "@article{30341867, title={The Influence of Metformin on Serum Carbohydrate Antigen 19-9 (CA 19-9) Levels in Type 2 Diabetes Mellitus Patients.}, author={Ankit BS and Agrawal R and Gadhwal A and Chahar C and Agrawal RP}, journal={J Assoc Physicians India}, volume={66}, number={3}, pages={38-41}}"}}]}